DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Reuken PA, Kiehntopf M, Stallmach A, Bruns T.
Mid-regional pro-adrenomedullin (MR-proADM): an even better prognostic biomarker than C-reactive protein to predict short-term survival in patients with decompensated cirrhosis at risk of infection?.
J Hepatol 2012;
57 (05) 1156-1158 , author reply 1158–1159
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.